Current treatment options for perinatal depression
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Perinatal depression (PND) screening and treatment are crucial for maternal health. New therapies and digital tools offer improved outcomes for parents and infants, but require careful integration.
Area Of Science
- Obstetrics and Gynecology
- Psychiatry
- Maternal-Fetal Medicine
Background
- Perinatal depression (PND) affects a significant portion of patients, contributing to maternal mortality.
- Despite its prevalence, PND remains underdiagnosed and undertreated, highlighting a critical gap in maternal healthcare.
- This review synthesizes current knowledge on PND screening, treatment, and novel therapeutic approaches.
Purpose Of The Study
- To provide an updated, clinically relevant review of perinatal depression.
- To synthesize current evidence on screening methods, established treatments, and emerging therapies for PND.
- To inform clinical practice regarding the diagnosis and management of PND.
Main Methods
- Systematic review of current literature and clinical guidelines.
- Analysis of recent findings on pharmacological and non-pharmacological treatments for PND.
- Evaluation of emerging technologies and interventional psychiatry for PND management.
Main Results
- Universal screening for PND using validated tools is recommended.
- Selective serotonin reuptuptake inhibitors are first-line treatments, with demonstrated safety during pregnancy and lactation.
- Emerging treatments include the neurosteroid zuranolone for rapid postpartum depression relief, and interventional psychiatry options like ketamine and TMS for select patients.
- Digital tools and AI show potential for early detection and personalized interventions, pending further validation.
Conclusions
- Individualized, evidence-based treatment is essential for optimizing maternal and neonatal outcomes in PND.
- A combination of pharmacologic and non-pharmacologic interventions can significantly improve outcomes for both parent and child.
- New therapeutic agents and digital innovations hold promise for PND care but necessitate careful clinical integration.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...